Viewing Study NCT00243204

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:10 PM
Ignite Modification Date: 2026-02-24 @ 2:06 PM
Study NCT ID: NCT00243204
Status: TERMINATED
Last Update Posted: 2007-06-08
First Post: 2005-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
Sponsor: Point Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small Cell Lung View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Stage IIIb/IV non-small cell lung cancer View
None NSCLC View
None Lung Cancer View